IND submission marks Matter Bio's transition toward clinical stage and advances its lead Listeria-based immunotherapy into one of oncology's highest-need indications If the IND is cleared by the FDA, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In December, Baudax Bio filed a ...
Motif Bio, which is developing novel antibiotics effective against multi-drug resistant bacteria, filed on Wednesday with the SEC to raise up to $40 million in an initial public offering. The company ...
Tevogen Bio files additional AI-related patent to enhance drug discovery and develops T cell therapies for infectious diseases and cancers. Tevogen Bio, a clinical-stage biotech company specializing ...
This post will show you how to recover BIOS settings in HP, ASUS, Dell, and other laptops. This can be useful if your Windows computer does not start. BIOS stands for Basic Input Output System. It is ...
BALTIMORE, Jan. 12, 2026 /PRNewswire/ -- IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under ...
IND submission marks Matter Bio's transition toward clinical stage and advances its lead Listeria-based immunotherapy into one of oncology's highest-need indications SAN FRANCISCO, May 19, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results